Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("RITCHIE, A. A")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 12 of 12

  • Page / 1
Export

Selection :

  • and

Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancerMCPHILLIPS, F; MULLEN, P; MONIA, B. P et al.British journal of cancer. 2001, Vol 85, Num 11, pp 1753-1758, issn 0007-0920Article

Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogenLANGDON, S. P; GABRA, H; BARTLETT, J. M. S et al.Clinical cancer research. 1998, Vol 4, Num 9, pp 2245-2251, issn 1078-0432Article

The relative importance of proliferation and cell death in breast cancer growth and response to tamoxifenCAMERON, D. A; RITCHIE, A. A; MILLER, W. R et al.European journal of cancer (1990). 2001, Vol 37, Num 12, pp 1545-1553, issn 0959-8049Article

Antitumour activity and schedule dependency of 8-chloroadenosine-3', 5'-monophosphate (8-ClcAMP) against human tumour xenograftsLANGDON, S. P; RITCHIE, A. A; MUIR, M et al.European journal of cancer (1990). 1998, Vol 34, Num 3, pp 384-388, issn 0959-8049Article

Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivoLANGDON, S. P; RABIASZ, G. J; RITCHIE, A. A et al.Cancer chemotherapy and pharmacology. 1998, Vol 42, Num 5, pp 429-432, issn 0344-5704Article

Pharmacological determinants of the antitumour activity of mitomycin CSPANSWICK, V. J; CUMMINGS, J; RITCHIE, A. A et al.Biochemical pharmacology. 1998, Vol 56, Num 11, pp 1497-1503, issn 0006-2952Article

Critical analyses of data differences between FNMOC and AFGWC spawned SSM/I datasetsRITCHIE, A. A; SMITH, M. R; GOODMAN, H. M et al.Journal of the atmospheric sciences. 1998, Vol 55, Num 9, pp 1601-1612, issn 0022-4928Article

Pharmacokinetics, metabolism and tumour disposition of 8-chloroadenosine 3',5'-monophosphate in breast cancer patients and xenograft bearing miceCUMMINGS, J; LANGDON, S. P; RITCHIE, A. A et al.Annals of oncology. 1996, Vol 7, Num 3, pp 291-296, issn 0923-7534Article

In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancerAIRD, R. E; CUMMINGS, J; RITCHIE, A. A et al.British journal of cancer. 2002, Vol 86, Num 10, pp 1652-1657, issn 0007-0920Article

Effect of human recombinant interferon-α on the activity of cis-diamminedichloroplatinum(II) in human non-small cell lung cancer xenograftsFRENCH, R. C; BOWMAN, A; MACLEOD, K. G et al.Cancer investigation. 1995, Vol 13, Num 6, pp 595-603, issn 0735-7907Article

The comparative disposition of the pyrolloquinone GR63178A and its 9-hydroxy metabolite GR54374X in sensitive and resistant mouse colon adenocarinomaFRENCH, R. C; CUMMINGS, J; MACLELLAN, A et al.Cancer chemotherapy and pharmacology. 1993, Vol 32, Num 2, pp 156-161, issn 0344-5704Article

12-O-tetradecanoylphorbol 13-acetate induced differentiation in human lung squamous carcinoma cellsRABIASZ, G. J; LANGDON, S. P; ANDERSON, L et al.British journal of cancer. 1992, Vol 66, Num 3, pp 439-443, issn 0007-0920Article

  • Page / 1